From science to success: Closing the biotech launch gap
Published on March 10, 2025
The biotech industry is full of organizations that are brilliant at science. However, many stumble once they need to turn that science into a business. Teams get swept up in the breakthrough, trial results, and mechanism of action, but forget that none of it matters unless patients get access and prescribers adopt.
It’s easy to get blindsided by a “loving science, being lost in science” mindset. However, great data doesn’t automatically translate into market success. The bar for differentiation in crowded therapeutic areas is incredibly high. By the time commercial and access teams get to the table, key decisions are already locked in: trial endpoints that aren’t payer-relevant, comparator arms that don’t reflect real-…
